The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients

被引:2
|
作者
Braga-Diniz, Julia Mourao [1 ]
Santa-Rosa, Caroline Christine [1 ]
Martins, Renata de Castro [2 ]
Souza e Silva, Maria Elisa [1 ]
Vieira, Leda Quercia [3 ]
Ribeiro Sobrinho, Antonio Paulino [1 ]
机构
[1] Univ Fed Minas Gerais, Sch Dent, Dept Operat Dent, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil
来源
BRAZILIAN ORAL RESEARCH | 2017年 / 31卷
关键词
Immunosuppression; Hematopoietic stem cell transplantation; Endodontics; DNA-DNA HYBRIDIZATION; MARROW-TRANSPLANTATION; GLOBAL PERSPECTIVE; INFECTIONS; MICROBIOTA; LEUKEMIA; RECIPIENTS; BACTERIA; DISEASE; BLOOD;
D O I
10.1590/1807-3107BOR-2017.vol31.0050
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The aim of this study is to investigate the relationship between the epidemiological and clinical profiles of patients before and after hematopoietic stem cell transplantation (HSCT) and the need for endodontic treatment. The subjects included 188 individuals enrolled in the dental care program for transplanted patients of the School of Dentistry, Federal University of Minas Gerais (Faculdade de Odontologia da Universidade Federal de Minas Gerais, FO-UFMG) from March 2011 through March 2016. The patients were subjected to an HSCT conditioning dental regimen based on a thorough clinical and radiographic evaluation. Intraoral periapical and bite-wing X-rays were obtained, and after evaluation, specific dental treatment was planned and performed. The following demographic and clinical data were collected from the patients' medical records: age, gender, transplantation stage, primary disease, transplant type, medication used, complete blood count at the time of visit, and need for endodontic treatment. The Kolmogorov-Smirnov and the chi-square tests were used. Leukemia (31.3%) and multiple myeloma (17.9%) were the most prevalent primary diseases. Most patients were subjected to allogeneic-related transplantation (83.6%). Most patients exhibited platelet counts and hemoglobin concentrations below the reference values in the pre-transplantation stage, while the neutrophil and platelet counts and the hemoglobin levels were within the reference ranges in the post-transplantation stage. The proportions of individuals requiring endodontic treatment were similar between the pre-and post-transplantation groups: 24.3% and 24.7%, respectively. The systemic conditions of the patients referred for dental treatment were compromised.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Endodontic Treatment in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
    Mota, Maria Emilia
    Siqueira Jr, Jose F.
    Rocas, Isabela N.
    Alves, Fabio Abreu
    Jaguar, Graziella Chagas
    Franco, Juliana Bertoldi
    Schmidt Filho, Jayr
    Moreira, Maria Stella
    JOURNAL OF ENDODONTICS, 2025, 51 (01) : 35 - 42
  • [2] Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
    Del Papa, Nicoletta
    Pignataro, Francesca
    Zaccara, Eleonora
    Maglione, Wanda
    Minniti, Antonina
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis, an Option for Refractory Patients
    Sossa, Claudia
    Figueroa, Javier
    Manuel Herrera, Juan
    Pena, Angela M.
    Salazar, Luis A.
    Rosales, Manuel
    Pedraza, Enrique
    Mora, Elena
    Chen, Xueyi
    Luna-Gonzalez, Maria
    Patricio Lopez-Lopez, Jose
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 227 - 228
  • [4] Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation
    Goldberg, Jeffrey L.
    Rocca, Celine
    Kreymerman, Alex
    Cherqui, Stephanie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Autologous hematopoietic stem cell transplantation in the treatment of systemic lupus erythematosus
    Zhao, X
    Fu, Y
    Peng, X
    BONE MARROW TRANSPLANTATION, 2002, 29 : S15 - S15
  • [6] Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation
    Perez, Victor L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (13) : 8361 - 8361
  • [7] Treatment of Inherited Eye Defects By Systemic Hematopoietic Stem Cell Transplantation
    Rocca, Celine J.
    Kreymerman, Alexander
    Ur, Sarah N.
    Frizzi, Katie E.
    Naphade, Swati
    Lau, Athena
    Tran, Tammy
    Calcutt, Nigel A.
    Goldberg, Jeffrey L.
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2015, 23 : S282 - S282
  • [8] Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation
    Rocca, Celine J.
    Kreymerman, Alexander
    Ur, Sarah N.
    Frizzi, Katie E.
    Naphade, Swati
    Lau, Athena
    Tran, Tammy
    Calcutt, Nigel A.
    Goldberg, Jeffrey L.
    Cherqui, Stephanie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (12) : 7214 - 7223
  • [9] Nonmyeloablative hematopoietic stem cell transplantation for the treatment of systemic sclerosis.
    Shiratsuchi, M
    Motomura, S
    Ikuta, T
    Ohno, H
    Shiokawa, S
    Nishimura, J
    BLOOD, 2004, 104 (11) : 340B - 340B
  • [10] Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus
    Champ, Alberto M. Marmont du Haut
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,